A study evaluating the efficacy and safety of GDC-0449 in operable basal cell carcinoma (BCC).(NON-MELANOMA SKIN CANCER): An article from: Journal of Drugs in Dermatology

This digital document is an article from Journal of Drugs in Dermatology, published by Journal of Drugs in Dermatology, Inc. on February 1, 2011. The length of the article is 401 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: A study evaluating the efficacy and safety of GDC-0449 in operable basal cell carcinoma (BCC).(NON-MELANOMA SKIN CANCER)
Author: Unavailable
Publication:Journal of Drugs in Dermatology (Magazine/Journal)
Date: February 1, 2011
Publisher: Journal of Drugs in Dermatology, Inc.
Volume: 10 Issue: 2 Page: 206(1)

Distributed by Gale, a part of Cengage Learning